Evidence map›Paper›PMID 41727465›Full record

ArticleFrontiers in immunology2026

Impact of rice wine-steamed

Jing Lian, Yuexin Zhu, Qiushi Hu, Kexu Dong, Zihang Peng, Yurou Feng, Na Ling, Caina Yu, Pengpeng Liu, Xuefei Lei and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jing LianLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Yuexin ZhuAnhui Jiren Pharmaceutical Co., Ltd, Anhui, China.
Qiushi HuLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Kexu DongLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Zihang PengLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Yurou FengLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Na LingLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Caina YuLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Pengpeng LiuLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Xuefei LeiLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Ji ShiLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.
Tianzhu JiaLiaoning University of Traditional Chinese Medicine, Department of Pharmacy, Dalian, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: The physicochemical properties of RCP and WCP were characterized using SEM, HPGPC, FT-IR, and GC-MS. Immunosuppressed mice induced by cyclophosphamide (CTX) were used as an Results: Wine processing significantly modified the polysaccharides, increasing polysaccharide content, markedly reducing molecular weight, and altering monosaccharide composition in WCP. In CTX-induced mice, WCP administration showed superior immunomodulatory effects: it significantly improved spleen and thymus indices, elevated serum IL-2, IFN-γ, IgA, and IgM levels, and increased the CD4+/CD8+ ratio. Furthermore, WCP restored CTX-disturbed intestinal SCFA levels and positively modulated gut microbiota by increasing Bacteroidetes and beneficial probiotics, lowering the Discussion: Traditional rice-wine processing optimizes the molecular structure of Cistanche polysaccharides and significantly enhances their immunomodulatory efficacy in a cyclophosphamide-induced immunosuppression model. The enhanced activity is associated with marked improvements in gut microbiota composition and systemic immune parameters, suggesting involvement of the gut-immune axis. These findings provide a scientific basis for the traditional processing method and support the further development of processed Cistanche as a potential functional food or therapeutic agent.

Indexed as

CistancheGastrointestinal MicrobiomeImmunomodulationOryzaPolysaccharidesWineAnimalsCyclophosphamideCytokinesImmunocompromised HostImmunosuppressive AgentsMaleMiceSpleenCyclophosphamideCytokinesImmunosuppressive AgentsPolysaccharidesCD4+/CD8+Cistanche deserticola polysaccharidecyclophosphamidegut microbiotaimmune regulationshort-chain fatty acids

Identifiers

PMID41727465
PMCPMC12916368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.